Treatment options for extended-spectrum β-lactamase-producers
Open Access
- 1 September 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 190 (2) , 181-184
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam AntibioticsClinical Infectious Diseases, 1997
- The Relationship Between Antecedent Antibiotic Use and Resistance to Extended-Spectrum Cephalosporins in Group I -Lactamase-Producing OrganismsClinical Infectious Diseases, 1995
- Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genesAntimicrobial Agents and Chemotherapy, 1993
- Survey of the prevalence of βlactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London HospitalJournal of Antimicrobial Chemotherapy, 1992
- Characterization of the plasmid mediated β-lactamase BIL-1Journal of Antimicrobial Chemotherapy, 1992
- More extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1991
- Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityAntimicrobial Agents and Chemotherapy, 1990
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1990
- Epidemiology of extended spectrum β-lactamasesInfection, 1989
- Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1989